Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BAT8009

Clinical trial NCT05405621 · UNKNOWN

Trial details

NCT number: NCT05405621
Sponsor: Bio-Thera Solutions
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced/Metastatic Solid Tumours

Start date: 2022-08-02
Primary completion: 2023-12-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.